Akkermansia muciniphila is a next-generation probiotic with significant application
prospects. The role of A. muciniphila in metabolic diseases and tumor immunotherapy has …

Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, is a chronic
relapsing gastrointestinal inflammatory disease mediated by dysregulated immune …

As one of the promising next-generation probiotics (NGPs), Akkermansia muciniphila, a well-
known mucin-degrading bacterium, has been proven to be closely related to the metabolic …

Although the exact pathophysiology remains unknown, the development of inflammatory
bowel disease (IBD) is influenced by the interplay between genetics, the immune system …

Diet is an important determinant of health and consequently is often implicated in the
development of disease, particularly gastrointestinal (GI) diseases, given the high …

Exclusive enteral nutrition (EEN) is the first line therapy for paediatric Crohn's disease,
providing a complete nutritional feed whilst simultaneously inducing remission in up to 80 …

Background The microbiome has been implicated in the initiation and persistence of
inflammatory bowel disease. Despite the fact that diet is one of the most potent modulators of …

Aims Exclusive enteral nutrition [EEN] is as efficacious as corticosteroids [CS] to induce
remission in Crohn's disease [CD], without their adverse effects. EEN seems to be more …

Crohn's disease (CD), a form of inflammatory bowel disease (IBD), is thought to arise from a
complex interaction of genetics, the gut microbiome, and environmental factors, such as diet …

Background The gut microbiota has been implicated in the pathogenesis of inflammatory
bowel disease (IBD), with Faecalibacterium prausnitizii associated with protection, and …